The Fabry registry, a scientific tool to outline the natural course of Fabry disease

被引：0
|
作者：
Fletcher, J.
Nicholls, K.
Shi, H.
Yoo, H-W
Denaro, C. P.
Yang, C-C
Chu, S. Y.
Kim, H.
Teo, S. H.
Niu, D-M
Chiu, P. C.
Sillence, D. O.
机构：
[1] Womens & Childrens Hosp, Adelaide 100730, SA, Australia
[2] R Melbourne Hosp, Inst Basic Med Sci, Parkville, Vic, Australia
[3] Chinese Acad Med Sci, Beijing, Peoples R China
[4] Asan MC, Song Pa Ku, South Korea
[5] R Brisbane & Womens Hosp, Brisbane, Qld, Australia
[6] Natl Taiwan Univ Hosp, Taipei 441749, Taiwan
[7] Tzu Chi MC, Sch Med, Hualien, Taiwan
[8] Ajou Univ, Suwon, South Korea
[9] KK Womens & Childrens Hosp, Singapore, Singapore
[10] Taipei Vet Gen Hosp, Taipei, Taiwan
[11] Vet Gen Hosp, Kaohsiung, Taiwan
[12] Childrens Hosp, Westmead, NSW, Australia
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2006年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [21] Natural history data from 182 female patients with Fabry disease in Latin America: A Fabry Registry analysis of disease burden
    Martins, Ana Maria
    Varas, Carmen
    Molt, Fernando
    Lemay, Roberta
    Politei, Juan M.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S91 - S92
  • [22] Natural history of Fabry disease in females in the Fabry outcome survey
    Deegan, PB
    Baehner, AF
    Romero, MAB
    Hughes, DA
    Kampmann, C
    Beck, M
    JOURNAL OF MEDICAL GENETICS, 2006, 43 (04) : 347 - 352
  • [23] The Natural History of Fabry Disease
    Warnock, David G.
    CLINICAL THERAPEUTICS, 2010, 32 : S101 - S102
  • [24] Fabry's Disease: New concepts in its natural history, evolution and treatment, in relation to the findings in the Fabry's Registry
    Politei, Juan Manuel
    Cabello, Juan Francisco
    Villalobos, Jacobo
    Valadez, Guillermo
    Loaeza, Antonio
    Linares, Adriana
    Martins, Ana Maria
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2009, 29 (04): : 145 - 152
  • [25] Prevalence of Lymphedema in Anderson-Fabry Disease a Report From the Fabry Registry
    Jefferies, John L.
    Hopkin, Robert
    CIRCULATION, 2018, 138
  • [26] Natural course of Fabry disease and impact of enzyme replacement therapy - Commentary
    Widmer, U
    ACTA PAEDIATRICA, 2005, 94 : 9 - 10
  • [27] Life expectancy and cause of death in Fabry disease: Findings from the Fabry Registry
    Banikazemi, Maryam
    Patel, Manesh
    Lemay, Roberta
    Waldek, Stephen
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S10 - S10
  • [28] Fabry cardiomyopathy in Finland: A Fabry registry study
    Effati, Paivi Pietila
    Valtola, Kati
    Walls, Susanne
    Kantola, Ilkka
    Kuusisto, Johanna
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S97 - S98
  • [29] Early therapy in Fabry disease: Outcomes from the Canadian Fabry Disease Initiative (CFDI) registry
    West, Michael L.
    Bichet, Daniel G.
    Iwanochko, Mark
    Khan, Aneal
    Sirrs, Sandra
    LeMoine, Kaye M.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 135 - 135
  • [30] SUBSTANTIAL SIGNS AND SYMPTOMS OF FABRY DISEASE AMONG CHILDREN: NATURAL HISTORY DATA FROM 352 PEDIATRIC PATIENTS IN THE FABRY REGISTRY
    Hopkin, R. J.
    Bissler, J.
    Banikazemi, M.
    Clarke, L.
    Eng, C. M.
    Germain, D. P.
    Lemay, R.
    Tylki-Szymanska, A.
    Wilcox, W. R.
    CLINICAL THERAPEUTICS, 2009, 31 : S29 - S29
12345